source
- Stakeholders urge FDA to adopt flexible approach for psychedelic drug regulationVarious individuals and groups have submitted comments urging the U.S. Food and Drug Administration to be flexible in regulating psychedelic medicines that could treat major depressive disorder and…
- Roche signs $1.2B partnership with China’s Rona for obesity drug as Stryker pours $400M into CMR SurgicalRoche has entered a $1.2 billion agreement with Chinese firm Rona to advance an obesity treatment, targeting the growing market for weight‑loss therapies in China. The deal will combine Roche’s dr…